Efficacy of Diaphragmatic Proprioceptive Neuromuscular Facilitation on Functional Capacity and Pulmonary Function in Heavy Twenties Smokers

NCT ID: NCT07003893

Last Updated: 2025-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-05

Study Completion Date

2025-11-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Although research on the health risks of e-cigarettes is still limited, there is increasing evidence of debilitating lung disease and general immune dysfunction from e-cigarettes, leading to various infections. Moreover, there are concerns that e-cigarettes can cause general impairment in life functions and more importantly lung function .Although exercise can help quit smoking and reduce relapses .However, exercise has many other fitness benefits when done regularly for the general population, as well as for smokers. Exercise has been shown to help with smoking cessation, which has been an important factor preventing many smokers, especially younger people, from quitting. Breathing exercises, especially diaphragm exercises improves lung function, lifestyle and health risk factors and thus the risk of developing many chronic diseases. Both aerobic interventions and exercise can reduce the incidence of many of the prevalent cancers initiated by smoking, such as lung cancer. This is important because lung cancer is the most common type of cancer worldwide, and cigarette smoking is responsible for up to 90% of lung cancer cases worldwide.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

According to predictions by the World Health Organization, the number of smokers who will die from cigarette related diseases will surpass the number of people dying from AIDS, traffic accidents, suicide, and murder combined by 2020. Due to the presence of various harmful substances in cigarettes, smoking can cause many diseases. Nicotine which is one of the major constituents of cigarettes causes arteriosclerosis, coronary artery disease, chronic obstructive pulmonary disease (COPD), and other problems that result not only in low cardiopulmonary function but also in relatively diminished daily living ability and endurance in smokers compared with that in non-smokers. Moreover, it is common knowledge that smoking is very highly correlated with occurrence of respiratory diseases. Diaphragmatic breathing is a good technique for respiration and relaxation of the lungs because it enables sufficient exchange of oxygen and carbon dioxide. Diaphragmatic breathing is reported to be effective in improvement of ventilation efficiency, dyspnea, and activity ability; reduction of metabolic acidosis; alleviation of back pain; spine correction; abdominal strengthening; and improvement of body composition and flexibility. In our current social climate, the number of male smokers in their twenties is rapidly increasing and this trend is becoming a social problem. Our study attempts to verify the effects of diaphragmatic proprioceptive neuromuscular facilitation on functional capacity and pulmonary functions in in heavy twenties smokers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Dependence Smoking Among Youth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

perform exercises using aerobic exercises only

Group Type ACTIVE_COMPARATOR

Diaphragmatic Proprioceptive Neuromuscular Facilitation + Aerobic exercises

Intervention Type OTHER

Control group will perform aerobic exercises only Experimental group will perform diaphragmatic proprioceptive neuromuscular facilitation in addition to aerobic exercises

Experimental group

perform diaphragmatic proprioceptive neuromuscular facilitation and aerobic exercise

Group Type EXPERIMENTAL

Diaphragmatic Proprioceptive Neuromuscular Facilitation + Aerobic exercises

Intervention Type OTHER

Control group will perform aerobic exercises only Experimental group will perform diaphragmatic proprioceptive neuromuscular facilitation in addition to aerobic exercises

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diaphragmatic Proprioceptive Neuromuscular Facilitation + Aerobic exercises

Control group will perform aerobic exercises only Experimental group will perform diaphragmatic proprioceptive neuromuscular facilitation in addition to aerobic exercises

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 20-29 years.

* Subjects who have been smoking for 1 to 3 years.
* Subjects who not receiving medical treatment for respiratory diseases.
* Subjects who have clean family medical history.

Exclusion Criteria

* Subjects who smoke cigars other than filtered cigarettes or tobacco pipes.

* Subjects with respiratory proplems.
* Participation in another clinical trial within the last 30 days.
* Endocrine and metabolic disorders (eg, hypothyroidism, hypercalcemia, diabetes mellitus, diabetes insipidus).
* Neurologic and psychiatric disorders (who can not understand the research project ).
Minimum Eligible Age

20 Years

Maximum Eligible Age

29 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Al-Zaytoonah University of Jordan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Saied Zidan

Assistant prof dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mohamed Saied Zidan

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB # 23/3/2024-2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exercise for Depressed Smokers
NCT02086149 COMPLETED NA
Impact of E-cigarette Use on the Body
NCT04972513 ACTIVE_NOT_RECRUITING
Examining Yoga's Effects on Smoking
NCT02181179 COMPLETED NA
Early Tobacco Abstinence - 5
NCT00224965 TERMINATED PHASE1